[BRAF V600E Mutation and TERT Promoter Mutation in Papillary Thyroid Carcinomas and Their Association with Clinicopathological Characteristics].

OBJECTIVE: promoter mutations with the clinicopathological features in papillary thyroid carcinoma (PTC). METHODS: promoters were examined by PCR-direct sequencing in tumor tissues from 326 PTC patients, while the relationships between the gene mutations and clinicopathological features were analyzed. RESULTS: < 0.05). CONCLUSION: promoter mutations in PTC shows more aggressive tumor behavior.